U.S. flag An official website of the United States government
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Drugs
Inactive Ingredient
Reason for Announcement:
Recall Reason Description
Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA)
Company Name:
Camber Pharmaceuticals, Inc.
Brand Name:
Brand Name(s)
Camber Pharmaceuticals, Inc.
Product Description:
Product Description
Losartan Tablets USP 25 mg, 50 mg, and 100 mg

Company Announcement

Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).

NMBA is a potential human carcinogen. To date, Camber has not received any reports of adverse events related to this recall.

Losartan Potassium, USP, is a prescription medication used to treat high blood pressure and congestive heart failure and is packaged in 30ct, 90ct, 500ct, 1000ct bottles. The identifying NDC #s associated with Camber’s product as are follows: Losartan 25 mg 31722-700-90, 31722-700-05, 31722-700-10; Losartan 50 mg 31722-701-30, 31722-701-90, 31722-70-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10.

The affected Losartan includes 87 lot numbers which are listed below:

NDC Name and Strength Count Lot# Expiry
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17026B Sep-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17050 Sep-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17051 Sep-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17052 Sep-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17053 Sep-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP17061 Oct-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP18035 Dec-19
31722-700-90 Losartan Potassium Tablets USP 25 mg 90 LOP18036 Dec-19
31722-700-05 Losartan Potassium Tablets USP 25 mg 500 LOP17026 Sep-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP17006 May-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP17025 Sep-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP17068 Oct-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP18037 Dec-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP18038 Dec-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP18039 Dec-19
31722-700-10 Losartan Potassium Tablets USP 25 mg 1000 LOP18057 Jan-20
31722-701-30 Losartan Potassium Tablets USP 50 mg 30 LOP17028C Sep-19
31722-701-30 Losartan Potassium Tablets USP 50 mg 30 LOP17064A Nov-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17027 Sep-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17063 Nov-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17093 Nov-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17094 Dec-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17095 Dec-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17097A Dec-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17105 Dec-19
31722-701-90 Losartan Potassium Tablets USP 50 mg 90 LOP17107 Dec-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17004 Dec-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17028B Sep-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17048 Oct-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17049 Oct-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17056 Nov-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17073 Nov-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17074 Nov-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17076 Nov-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP17096 Dec-19
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18077A Feb-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18078 Feb-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18079 Feb-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18080 Feb-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18081 Mar-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18084 Mar-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18095 Mar-20
31722-701-10 Losartan Potassium Tablets USP 50 mg 1000 LOP18096 Mar-20
31722-702-30 Losartan Potassium Tablets USP 100 mg 30 LOP17011 Aug-19
31722-702-30 Losartan Potassium Tablets USP 100 mg 30 LOP17087 Nov-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17012 Aug-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17013 Aug-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17042 Oct-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17043 Oct-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17044 Nov-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP17045 Nov-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18024 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18025 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18026 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18027 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18028 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18029 Dec-19
31722-702-90 Losartan Potassium Tablets USP 100 mg 90 LOP18030 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17005 May-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17014 Aug-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17016 Sep-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17023 Sep-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17083 Oct-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17084 Nov-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17085 Nov-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP17086 Nov-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18021 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18022 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18023 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18031 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18032 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18033 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18050 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18051 Dec-19
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18109 Mar-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18111 Mar-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18122 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18123 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18124 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18125 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18126 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18127 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18128 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18129 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18130 Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18131C Jun-20
31722-702-10 Losartan Potassium Tablets USP 100 mg 1000 LOP18133 Jun-20

Losartan Potassium Tablets were distributed Nationwide to Wholesalers, Distributors, Retail Pharmacies, and Mail Order Pharmacies.

Stericycle is notifying Camber’s distributors and other customers by recall letter and arranging for return of recalled product of Losartan Potassium Tablets.

Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking the product. Pharmacies and healthcare facilities that have the product being recalled should stop using and dispensing the product immediately.

Consumers with questions regarding this recall can contact Camber Pharmaceuticals’ Med Line at 1-866-495-1995 Monday – Friday, 9am – 5pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch

Adverse reactions or quality problems associated with the use of this product may be reported to FDA's MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug administration.

 


Company Contact Information

Consumers:
Camber Pharmaceuticals’ Med Line
1-866-495-1995
Media:
Stericycle Customer Service – Recalls – Event 4862
1-888-275-0506
Camber4862@stericycle.com

Product Photos

 
Back to Top